US-based bioabsorbable scaffold company R3 Vascular has been granted investigational device exemption (IDE) approval by the ...

"FDA grants clearance for study of Envoy Medical’s cochlear implant" was originally created and published by Medical Device ...

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its drug-eluting ...

Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).

Envoy Medical (COCH) announces that its Investigational Device Exemption, IDE, application for its pivotal study of the Acclaim Fully Implanted ...

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the US Food and Drug Administration has approved its ...

The Acclaim® Fully ImplantedCochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients ...

The result calls into question the prospects of FDA approval for the Acurate neo2 valve, which is already in use globally.

Envoy Medical (COCH) announces that its Investigational Device Exemption, IDE, application for its pivotal study of the Acclaim Fully Implanted Cochlear Implant has been approved by the U.S. Food ...

Larry Jones, Johnson & Johnson Medtech’s chief information officer, will resign after more than three decades with the ...